1. Merck to buy Pandion for $1.9B for its immune modulators — Biden looking beyond Woodcock or Sharfstein for FDA commmisioner — Former AveXis execs launch gene therapy startup See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Here come the layoffs.....

Discussion in 'Exact Sciences' started by anonymous, Apr 3, 2020 at 3:24 PM.

  1. anonymous

    anonymous Guest

    Nothing you can do right now will make a difference on your future no matter what your Area Manager tells you. That comes down to a map that the Consulting Company created. Good Luck.
  2. anonymous

    anonymous Guest

  3. anonymous

    anonymous Guest

    Last in First out. Managers, PMRs and etc. ISRs inside too. Overlay expansion an absolute disaster. Bring nothing but disruption and they sure as hell aren’t driving any business because they don’t have established relationships in systems and offices. Want to save money... thats where you start.